The original Patent Reform Act of 2005 introduced by Rep. Lamar Smith (R-Texas) featured a provision that would restrict patent holders' ability to obtain court orders to halt the sale of products that potentially infringe on their patents. This was one of many reforms desired by the high-tech industry, which wants to deter "patent trolls" who generate profits without producing anything by acquiring patents and then suing others for infringement. (ap)

however, biotech companies and pharmaceutical ones are against it. 'drug industry's ability to innovate', would be at danger ...